Derma Sciences Inc  

(Public, NASDAQ:DSCI)   Watch this stock  
Find more results for DSCI
-0.31 (-3.69%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.05 - 8.56
52 week 7.27 - 12.02
Open 8.38
Vol / Avg. 94,142.00/114,053.00
Mkt cap 207.97M
P/E     -
Div/yield     -
EPS -1.59
Shares 25.71M
Beta 0.87
Inst. own 87%
May 6, 2015
Q1 2015 Derma Sciences Inc Earnings Release (Estimated) Add to calendar
Mar 12, 2015
Q4 2014 Derma Sciences Inc Earnings Call - Webcast
Mar 12, 2015
Q4 2014 Derma Sciences Inc Earnings Release
Mar 10, 2015
Derma Sciences Inc at ROTH Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -41.83% -47.49%
Operating margin -41.68% -47.89%
EBITD margin - -43.18%
Return on average assets -26.75% -34.91%
Return on average equity -29.52% -39.24%
Employees 299 -
CDP Score - -


214 Carnegie Ctr Ste 300
PRINCETON, NJ 08540-6237
United States - Map
+1-609-5144744 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Derma Sciences, Inc. (Derma Sciences) is a tissue regeneration company. The Company is focused on three segments of the wound care marketplace: advanced wound care, which provides Medihoney dressings, Bioguard, Xtrasorb, TCC-EZ, ALGICELL AG and DERMAGRAN products; traditional wound care, which offers branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets; and pharmaceutical wound care, which offers DSC127, an angiotensin analog. The Company markets its products principally through direct sales representatives in the United States, Canada and the United Kingdom, and through independent distributors within other international markets. The Company�s U.S. distribution facilities are located in St. Louis, Missouri and Houston, Texas. The Company has manufacturing facilities in Toronto, Canada and Nantong, China.

Officers and directors

Edward J. Quilty Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
John E. Yetter CPA Chief Financial Officer, Executive Vice President - Finance
Age: 62
Bio & Compensation  - Reuters
Robert C. Cole Group President - Traditional Wound Care and Corporate Accounts
Age: 62
Bio & Compensation  - Reuters
Barry J. Wolfenson Group President- Advanced Wound Care
Age: 48
Bio & Compensation  - Reuters
Frederic Eigner Executive Vice President - Operations; General Manager of Derma Sciences Canada, Inc.
Age: 65
Bio & Compensation  - Reuters
John Caminis Chief Medical Officer
Age: 55
Bio & Compensation  - Reuters
Bruce F. Wesson Vice Independent Lead Director
Age: 72
Bio & Compensation  - Reuters
Stephen T. Wills CPA Lead Independent Director
Age: 58
Bio & Compensation  - Reuters
Brett D. Hewlett Director
Age: 52
Bio & Compensation  - Reuters
Srini Conjeevaram Independent Director
Age: 56
Bio & Compensation  - Reuters